08.10.2026
Prof. Cunningham and Seemesh Bhaskar in the BioNano Lab (HMNTL).
"The real prize is time. In our own analysis of more than 11,000 lung-cancer patients, the molecular result that guides treatment took an average of 64 days to arrive, and point-of-care testing is about giving that time back to the patient."
"Because these tests are cheap and quick enough to repeat, a single snapshot mailed to a lab becomes a movie: you can watch a therapy working, or catch resistance the day it appears rather than months later."
Prof. Cunningham and Seemesh Bhaskar planning the Lab on a Chip ideas in the professor's office (HMNTL).
"The technological barriers are being systematically removed, and there are no fundamental physics or chemistry reasons why point-of-care cancer diagnostics can’t become a reality."
Prof. Cunningham discussing ideas with the Nanosensors group (HMNTL).